The approval of ipilimumab and vemurafenib in 2011 marked a significant advance in the treatment of melanoma, and a number of new investigational agents are in the pipeline.
Dragos Plesca, PharmD, PhD
Advertisement
Articles by Dragos Plesca, PharmD, PhD
Advertisement
Latest Updated Articles
- Melanoma: Therapy Update
Published: May 20th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Ban Synthetic 7-OH: Natural Leaf Kratom Presents No Major Health Risk
2
Is Berberine Nature’s GLP-1?
3
Pharmacists Key to Counseling and Monitoring Patients Transitioning to Low-Sodium Oxybate
4
Incidence of VAIs in Patients With Chronic Kidney Disease on Dialysis Relatively Low
5
